Healthcare


 Study suggests Pfizer-BioNTech vaccine is effective against new Covid-19 strain

Study suggests Pfizer-BioNTech vaccine is effective against new Covid-19 strain

January 10, 2021 12:05 AM GMT| By Kunal Sawhney

Summary Scientists have found evidence that proves the Pfizer and BioNTech vaccine, BNT162b2, is effective on the mutated version of coronavirus The Pfizer and BioNTech vaccine was the first one to be rolled out in Britain on 8 December A .....

 Covid-19 Vaccine: UK Authorise Moderna Vaccine for Mass Usage

Covid-19 Vaccine: UK Authorise Moderna Vaccine for Mass Usage

January 09, 2021 07:35 AM GMT| By Kunal Sawhney

Summary The UK Government has granted Moderna’s Covid-19 vaccine the Emergency Use Authorization for mass vaccination The Department of Health has said that the Moderna vaccine has met with the strict standards of safety, efficacy and qua.....

 Study claims Roche’s Arthritis Drug can treat Covid-19 patients, UK government gives nod

Study claims Roche’s Arthritis Drug can treat Covid-19 patients, UK government gives nod

January 08, 2021 03:29 PM GMT| By Kunal Sawhney

Summary Two drugs manufactured by Roche’s arthritis drugs -- Tocilizumab and Sarilumab were investigated in a UK-led study  The REMAP-CAP trial has indicated that these medicines are effective in treating severely ill coronavirus pat.....

 Avacta (LON: AVCT) Group Enters Licence Agreement with Point Biopharma

Avacta (LON: AVCT) Group Enters Licence Agreement with Point Biopharma

January 07, 2021 12:41 PM GMT| By Team Kalkine Media

Summary Avacta Group has joined forces with Point Biopharma Inc to accelerate the progress of tumour-activated radiopharmaceuticals The agreement will lead to proceeds of $9.5 million to Avacta Group, which comprises of an upfront fee and devel.....

 AstraZeneca (LON: AZN) vaccine rollout gets extended to general practitioners

AstraZeneca (LON: AZN) vaccine rollout gets extended to general practitioners

January 07, 2021 07:26 AM GMT| By Team Kalkine Media

Summary Government aims to vaccinate all the four most vulnerable groups within the next one and a half months’ period The UK’s National Health Service (NHS) has informed that some doctors’ practices would be able to offer.....

 AstraZeneca PLC’s (LON: AZN) Farxiga Secures US Priority Review

AstraZeneca PLC’s (LON: AZN) Farxiga Secures US Priority Review

January 06, 2021 04:58 PM GMT| By Kunal Sawhney

Summary AstraZeneca announced that it has been granted the Priority Review in the US foe Farxiga If approved, Farxiga (dapagliflozin) could be used in treating the patients of chronic kidney disease AstraZeneca PLC (LON: AZN) announce.....

 What’s in store for Healthcare Stocks in 2021: Top 5 picks 

What’s in store for Healthcare Stocks in 2021: Top 5 picks 

January 01, 2021 12:27 AM GMT| By Hina Chowdhary

Healthcare companies are active all year round irrespective of the global situation; hence it is always considered good to have a decent exposure in the healthcare stocks if one is making a portfolio. It is also considered as a popular trend, particu...

 After UK’s Approval, Mexico May Go Ahead with AstraZeneca-Oxford University Vaccine

After UK’s Approval, Mexico May Go Ahead with AstraZeneca-Oxford University Vaccine

December 31, 2020 10:49 AM GMT| By Team Kalkine Media

Summary Britain's approval of Oxford University and AstraZeneca’s coronavirus vaccine candidate, which was developed in record time, was hailed by Mexico's government Latin American nations such as Mexico, Argentina, and Chile are very cl.....

 Oxford University- AstraZeneca (LON: AZN) Covid-19 Vaccine Gets UK Regulator’s Nod

Oxford University- AstraZeneca (LON: AZN) Covid-19 Vaccine Gets UK Regulator’s Nod

December 30, 2020 09:20 AM GMT| By Kunal Sawhney

Summary MHRA has authorised Oxford University-AstraZeneca for emergency use of their COVID-19 Vaccine AstraZeneca’s vaccine achieved an overall efficacy level of 70 per cent The British drugmaker is closely working with the Public H.....

 AstraZeneca (LON: AZN) Receives US Approval for Lung Cancer Treatment

AstraZeneca (LON: AZN) Receives US Approval for Lung Cancer Treatment

December 22, 2020 08:30 AM GMT| By Kunal Sawhney

Summary AstraZeneca plc’s (LON: AZN) Tagrisso (osimertinib) has received approval in the US for the adjuvant medication of adult patients. The approval was received under the US Food and Drug Administration’s (FDA) Real-Time Oncolog.....

 Moderna Very Close to Getting US FDA Emergency Approval for Its Vaccine

Moderna Very Close to Getting US FDA Emergency Approval for Its Vaccine

December 18, 2020 11:24 AM GMT| By Hina Chowdhary

Summary On 17 December, a panel of independent US experts recommended the emergency approval for Moderna’s mRNA-based vaccine. Last week, the same panel had backed the Pfizer Inc/BioNTech SE vaccine. The Moderna vaccine has efficiency an.....

 AstraZeneca (LON: AZN) UK Vaccine Trial Withdraw Sub-Group

AstraZeneca (LON: AZN) UK Vaccine Trial Withdraw Sub-Group

December 15, 2020 09:07 AM GMT| By Hina Chowdhary

Summary The clinical trial registers in the US showed that the British pharma major AstraZeneca PLC has removed children from the final stage trial of its Covid-19 vaccine in Britain. The Phase 3 trial of the vaccine consisted of more than 12,0.....

 Will the US Face Critical Shortage of Covid-19 Vaccine Doses?

Will the US Face Critical Shortage of Covid-19 Vaccine Doses?

December 15, 2020 08:42 AM GMT| By Team Kalkine Media

There has been a wave of jubilation in the US after the Food and Drug Administration (FDA) granted the emergency use authorisation for the coronavirus vaccine co-developed by Pfizer Inc and BioNTech SE. As the US has the highest number of reported .....

 US FDA allows Pfizer-BioNTech Covid-19 vaccine for emergency use

US FDA allows Pfizer-BioNTech Covid-19 vaccine for emergency use

December 12, 2020 09:53 AM GMT| By Kunal Sawhney

  The US Food and Drug Administration (FDA) on Friday gave a go-ahead to Pfizer-BioNTech COVID-19 Vaccine for emergency use in the US. The FDA in a statement said that it is determined that Pfizer-BioNTech’s vaccine has met its statutor.....

 Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got delayed to 2021-end?

Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got delayed to 2021-end?

December 12, 2020 08:11 AM GMT| By Kunal Sawhney

Summary The Covid-19 vaccine jointly developed by Britain’s GSK and France’s Sanofi has been delayed to the end of 2021 Both the pharmaceutical companies are expected to start Phase 2b studies in February 2021 While the compani.....

 AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US Regulator

December 10, 2020 11:01 AM GMT| By Kunal Sawhney

Summary The executive vice-president at AstraZeneca biopharmaceuticals R&D Sir Menelas Pangalos has expressed his doubts over early FDA approval for their vaccine AstraZeneca has been facing criticism since it paused its Phase 3 trials in S.....

 Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial Resolution At AGM

December 09, 2020 09:10 AM GMT| By Team Kalkine Media

The fully integrated specialty pharmaceutical group, Allergy Therapeutics PLC has said that all the resolutions which were proposed at its Annual General Meeting (AGM) on Tuesday were passed, barring one the resolution 10. Resolution 10 talks abou.....

 Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high efficacy’: US FDA

December 09, 2020 08:45 AM GMT| By Team Kalkine Media

Summary US FDA has commended the expeditious response of Pfizer and BioNTech in Covid-19 vaccine development Pfizer-BioNTech co-developed coronavirus vaccine exhibits safety and overwhelmingly high efficacy In a further advancement in the .....

 What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

What are the progressive developments made by N4 Pharma in collaboration with Nanomerics Limited?

December 07, 2020 02:41 PM GMT| By Kunal Sawhney

Summary N4 Pharma Plc has reported an increase of 5.9% in operating loss during H1 FY20. The Company has started the first phase of research to test the stability of different formulations of Nuvec® in collaboration with Nanomerics Limited......

 Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, says Deputy CMO

December 04, 2020 06:03 AM GMT| By Kunal Sawhney

The United Kingdom administration is all set to get the very first doses of the clinically-approved coronavirus vaccine developed by Pfizer-BioNTech much ahead than other countries, especially the United States, where the vaccine is still under Foo.....

Recent Articles






Investing Tips

Previous Next